DNTH (Dianthus Therapeutics) Dividends per Share: $0.00 (TTM As of Mar. 2026)

What is Dianthus Therapeutics Dividends per Share?

Dianthus Therapeutics DNTH +4.58% 22 Dividends per Share is $0.00 as of Mar. 2026. GuruFocus rates DNTH with a GF Score™ of 22/100 and a GF Value™ of $2.91 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Dianthus Therapeutics's dividends per share for the three months ended in Mar. 2026 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Dianthus Therapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Dianthus Therapeutics (NAS:DNTH) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Dianthus Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	-0.843
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dianthus Therapeutics Dividends per Share Related Terms

Dianthus Therapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Dianthus Therapeutics's Dividends per Share can be seen below:

Dianthus Therapeutics Dividends per Share Chart

Dianthus Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

0.00

Dianthus Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial											0.00	0.00	0.00	0.00	0.00

DNTH vs CAI, TNGX, MANE: Dividends per Share Comparison

For the Biotechnology subindustry, Dianthus Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dianthus Therapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dianthus Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Dianthus Therapeutics's Dividend Yield % falls into.

Save Embed

22GF Score

Dianthus Therapeutics Inc DNTH

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Dianthus Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of $0.00 mean?

Dianthus Therapeutics (DNTH) has a Dividends per Share of $0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Dianthus Therapeutics and its competitors.

Is Dianthus Therapeutics' Dividends per Share too high?

Dianthus Therapeutics' current Dividends per Share is $0.00. Overall, Dianthus Therapeutics has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Dianthus Therapeutics' Dividends per Share compare to CAI and TNGX?

Dianthus Therapeutics' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Dianthus Therapeutics and its competitors. Dianthus Therapeutics's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Dianthus Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Dianthus Therapeutics (DNTH) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.91, compared to a current price of $94.34 — trading 3141.9% above its estimated fair value. The current Dividends per Share is $0.00. Dianthus Therapeutics' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Dianthus Therapeutics (DNTH), the current Dividends per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dianthus Therapeutics (DNTH) Overvalued in 2026?

Based on GuruFocus' analysis, Dianthus Therapeutics stock appears to be overvalued. The current stock price of $94.34 is trading 3141.9% above its estimated GF Value™ of $2.91. GuruFocus considers Dianthus Therapeutics to be Significantly Overvalued.

Key valuation signals for DNTH:

Dividends per Share: $0.00
GF Value™: $2.91 vs. price of $94.34 (3141.9% above fair value)
GF Score™: 22/100 with 7 warning signs

No single metric tells the full story. See the DNTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dianthus Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies CAI TNGX MANE CRSP ERAS ORKA TVTX CELC LEGN XENE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 87E:Germany

Address 7 Times Square, 43rd Floor, New York, NY, USA, 10036

Website https://www.dianthustx.com

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

22GF Score

Get the complete analysis for DNTH

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$94.34

Price

$2.91

GF Value

View DNTH Analysis

See Dividends per Share data for all stocks →